Dermatology

A small British study indicates that the use of several immunosuppressive agents can restore the effectiveness of ustekinumab (Stelara) in patients with psoriasis and psoriatic arthritis.

Options for treating atopic dermatitis topically are far too limited, a review has found.

Perceived stress and atopic dermatitis (AD) are associated, a Korean study finds.

Adults with atopic dermatitis are at greater risk of systemic infections.

Children are less likely to have atopic dermatitis when their mothers have higher levels of vitamin D.

While it has been known for some time that psoriasis patients are at increased risk of developing cardiovascular disease and other comorbidities, new research has shown that these patients also have a higher risk of developing aortic aneurysms.

Many psoriasis patients wish they were better informed of the significant impact their skin condition would have on their physical and mental health, according to results from Psoriasis in America 2016, a Health Union national survey.

Children suffering from generalized pustular psoriasis (GPP), who haven’t been responding favorably to traditional therapies, can potentially benefit from biologics treatment.

This most recent trial of the investigational agent E6005 follows on a previous study that evidenced benefit in adult patients.

Whether applied to skin that is presoaked or dry, there is no difference in the effectiveness of topical corticosteroids in treating atopic dermatitis, according to a new controlled comparison study in children.

Patients afflicted with severe psoriasis may be at higher risk for chronic pancreatitis (CP).

Analysis of data from 2 large trials finds that cutoffs used to separate different “disease activity states” on the Disease Activity index for Psoriatic Arthritis (DAPSA) are valid. Different disease activity states are associated with different degrees of functional impairment and joint damage progression.

Mark McClellan, MD, PhD, who served as FDA Commissioner and CMS Administrator, will be the keynote speaker at the fall meeting of the ACO & Emerging Healthcare Delivery Coalition, presented by The American Journal of Managed Care. The meeting will be October 20-21, 2016, in Philadelphia.

Researchers concluded that the drug secukinumab is associated with on-going inhibition of radiographic progression.

Taking the dual approach in biologic and phototherapy treatments appears to be a more beneficial clinical treatment method for patients suffering from moderate-to-severe psoriasis.

For millions of Americans, including as many as one in four children, the painful skin irritation of atopic dermatitis (AD, or eczema), may only be the tip of the iceberg.

Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom, potentially providing a candidate molecule to reflect disease’s severity.

The gut microbiome has previously been considered a therapeutic target for the immune system, and new research suggests the microbiome’s composition can hold the key to managing psoriasis.

Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom severity.

Treating atopic dermatitis in infants did not lessen their risk of developing asthma and allergic rhinitis, a six-year study found.

The FDA has approved UltraShape Power (Syneron Medical Ltd) for non-invasive reduction of abdominal circumference through fat cell destruction.

The US Food and Drug Administration's (FDA's) Arthritis Advisory Committee recently voted unanimously to recommend the approval of biosimilars to adalimumab (Humira) and etanercept (Enbrel).

A potential treatment for atopic dermatitis (AD) appears to improve patients' quality of life--including enabling many trial subjects to be more productive at work or school.

Award-winning chef Elizabeth Falkner and board-certified dermatologist Doris Day spoke with MD Magazine about their collaborative efforts on a new atopic dermatitis campaign, ‘Understand AD.’

From childhood to adulthood atopic dermatitis is a condition that can have an extremely negative impact on a person's life. Knowing the best way to manage the symptoms can go a long way in improving quality of life issues.

People with red hair, pale skin, and freckles have long been advised to take extra precautions when out in the sun. New research has supported these concerns by proving the MC1R gene variant associated with red hair was directly linked to a higher number of genetic mutations in skin cancers.

In a prelude to establishing research priorities to help patients with atopic dermatitis, the National Eczema Association is launching a Burden of Disease Audit.

Most psoriatic arthritis patients can maintain low disease activity on reduced doses of tumor necrosis factor inhibitors — but patients who experience flares after switching to the lower dose can struggle to regain control over their disease.

A new study found that female psoriasis patients have a fourfold increased risk of developing Crohn’s disease (CD).

Patients battling acne can now add a new medication to their regimen. The FDA has approved the over-the-counter (OTC) topical gel adapalene (Differin Gel 0.1%/Galderma Laboratories) for the treatment of acne in people 12 years or older.